Glaukos is a publicly traded U.S.-based ophthalmic medical technology and pharmaceutical company focused on developing and commercializing innovative therapies and devices for chronic eye diseases. The company is best known for pioneering Micro-Invasive Glaucoma Surgery (MIGS) and building a portfolio of micro-scale implantable devices designed to lower intraocular pressure safely and effectively. Key examples include the iStent®W and iStent infinite® systems, which improve aqueous outflow for patients with mild-to-moderate open-angle glaucoma.